Section Arrow
SRPT.NASDAQ
- Sarepta Therapeutics
Quotes are at least 15-min delayed:2025/06/12 23:56 EDT
Last
 37.31
-0.5 (-1.32%)
Day High 
37.84 
Prev. Close
37.81 
1-M High
44.14 
Volume 
3.20M 
Bid
37.22
Ask
37.57
Day Low
36.8 
Open
37.6 
1-M Low
34.1 
Market Cap 
3.72B 
Currency USD 
P/E 15.76 
%Yield -- 
10-SMA 39.12 
20-SMA 38.44 
50-SMA 47.63 
52-W High 173.25 
52-W Low 34.1 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.64/3.55
Enterprise Value
5.05B
Balance Sheet
Book Value Per Share
11.63
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
301.03M
Operating Revenue Per Share
11.24
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.152-0.013-7.88%-- 
KLTOKlotho Neurosciences Inc2+0.55+37.93%-- 
ONCOOnconetix Inc0.0741+0.0053+7.70%-- 
IPAImmunoPrecise Antibodies Ltd0.7299+0.1295+21.57%-- 
PLRZPolyrizon Ltd1.07+0.27+33.75%-- 
Quotes are at least 15-min delayed:2025/06/12 23:56 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.